HIV Archives

Calimmune completes $15M Series B financing


Calimmune Inc., a clinical-stage gene therapy company, has successfully completed its $15 million Series B financing round, led by a large pharmaceutical company. Alexandria Venture Investments also joined with existing investors including RA Capital Healthcare Fund LP and Translational Accelerator LLC. Proceeds will be used to progress the company’s ongoing HIV/AIDS clinical trials, advanced technology… Read More →

TGen study provides new insights on HIV


A new study led by the Translational Genomics Research Institute (TGen) provides insights into the interplay among bacteria, viruses and the immune system during HIV infection. Currently, doctors measure HIV-positive men’s infectivity — their potential to infect others — based on their blood viral load. However, some men produce large amounts of virus in their… Read More →

How could budget cuts impact Arizona?

marketing budget

The White House released a list of impacts to Arizona from automatic budget cuts that are set to take hold this week. The White House compiled the numbers from federal agencies and its own budget office. The numbers reflect the impact of the cuts this year. Unless Congress acts by Friday, $85 billion in cuts… Read More →